VYNE icon

VYNE Therapeutics (VYNE)

NASDAQ

$0.61

$0.00 (

0.00%

)

1D
5D
1M
6M
1Y
5Y
Pre market

VYNE: $0.61 / ₿ 0 BTC / 918 Sats

1D
5D
1M
6M
1Y
5Y

Key statistics

$0.61
$0.28 - $1.99
$20.33M
0.83
$99.00
33.32M
$0.57 - $0.63
No

What is VYNE Therapeutics (VYNE)?

VYNE Therapeutics Inc is a biopharmaceutical company focused on developing proprietary and differentiated therapies for the treatment of immuno-inflammatory conditions. The company is also in the pre-clinical stages of research, develop and commercialize products containing small molecule bromodomain and extra-terminal domain (BET) inhibitors for the treatment of any disease, disorder or condition in human. Its products include AMZEEQ, ZILXI, and FCD105.

The VYNE Therapeutics (VYNE) stock price has been falling

The VYNE Therapeutics Inc. Common Stock (VYNE) stock pre-market price today is $0.61, reflecting a 0.00% pre-market move since the market last closed. The company’s market capitalization stands at $20.33M, with a daily trading volume of $99.00 shares. The previous closing price was $0.61.

Get started with VYNE Therapeutics (VYNE)

Ready to get started? Follow the steps below, or read our guide on how to buy VYNE Therapeutics stock on Kraken starting from $10.

Create an account

Create an account

Open the Kraken app to confirm your eligibility and follow the steps for account verification.



Deposit funds

Deposit funds

Once your account has been verified and stock trading is unlocked, you can deposit funds into your account using your preferred payment method.

Buy

Buy VYNE

Search for VYNE in the Kraken app, enter the amount you want to invest, review the important details and tap Confirm to place an order to buy VYNE.

VYNE FAQs

VYNE is in the Healthcare sector. Sector is a broad classification that groups companies based on their business activities, industry focus or economic function.

VYNE is in the Biotechnology industry. Industry is a more specific classification within a sector, grouping companies that operate in a similar field and have closely related business models.

Over the past 52 weeks, VYNE Therapeutics Inc. Common Stock (VYNE) has traded between a low of $0.28 and a high of $1.99.

VYNE is in the Biotechnology industry group. Industry group is a further subdivision within an industry, grouping companies with even more closely related business models and operations. This helps investors analyze stocks at a more detailed level than sector and industry classifications alone.

Want to invest in VYNE Therapeutics? 
Get the Kraken app

Eligible US clients can now invest in over 11,000 stocks and ETFs - commission-free* - directly in the Kraken app. Download it and get started.

Fictional stock
USD icon
USD
VYNE icon
VYNE

Only available to USA clients through the Kraken app
or Kraken Pro.

Get the Kraken Pro app and buy VYNE Therapeutics in minutes

Kraken App QR Code

Explore other stocks

Most active

Explore the most-traded stocks today

GPUS icon
TMDE icon
AIXI icon

AIXI

Top gainers

Browse today’s biggest stock market winners

TMDE icon
HUBCW icon
TURB icon
SKYQ icon

Top losers

Compare the worst-performing stocks of 
the day

SDCCQ icon
YOTAR icon

YOTAR

ELAB icon
MOBXW icon

MOBXW

SXTPW icon

SXTPW

Want to learn more about equities?

Check out our Kraken Learn Center guides

Currently available in the U.S. only; may not be available in all states. Brokerage services are provided by Kraken Securities LLC, member FINRA/SIPC. Please view the firm’s profile, registration and background of our registered reps on https://brokercheck.finra.org/. Digital asset services offered by Payward Interactive, not a member of FINRA/ SIPC and not FDIC insured. This is not an offer, solicitation, inducement or advice to buy or sell securities, or open a brokerage account in any jurisdiction where Kraken Securities is not registered. All trading involves risk, including loss of your investments. View full disclosures at: Equities Disclosures and Crypto Risk Disclosures.

*Other applicable fees may apply.